“Lombardi's mission is to prevent, treat and cure cancers, through cutting-edge research, expert and compassionate patient care, education of future cancer specialists, and service to the community,” says the Georgetown University Lombardi Comprehensive Cancer Center funding application and project abstract listed on NIH RePORTER. The Lombardi Comprehensive Cancer Center was recently awarded $1.4 million this year. “Lombardi is the only NCI-designated cancer center in the nation's capital and in the Washington metropolitan area. The District of Columbia has among the highest cancer mortality rates in the country. Thus, there is a clear need for an NCI-designated comprehensive cancer center that can bring a targeted, evidence-based strategy to cancer care and prevention to help improve the health of the community's residents.”
Georgetown University receives a great deal of research funding every year. The university was awarded $53.5 million by the NIH in 2012, according to the NIH website. In addition to receiving NIH funding, Georgetown University also received $6 million from the NSF in 2012.
Georgetown BioResearch Product Faire™ Event 2012
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center received an NIH gift this year totaling $1.4 million in funding. The proposal for funding was submitted by Dr. Louis Weiner. According to the Georgetown University website, Dr. Weiner was named the director of the Lombardi Comprehensive Cancer Center in the fall of 2007. He is recognized worldwide as being a top medical oncologist specializing in gastrointestinal cancers, and his research focus is developing new immunotherapy treatments in his laboratory. The project abstract on the NIH RePORTER goes into more detail on the significance of Georgetown’s Lombardi Comprehensive Cancer Center:
“In the present application, Lombardi comprises 177 members (113 full members), participating in six research programs with the support of 12 shared resources, based primarily in two adjacent buildings. Peer-reviewed research annual direct funding for 2008 totaled $53 million, with $28.5 million coming from the NCI. This represents a significant increase in NCI funding compared with 2002. Lombardi clinical activities are carried out in conjunction with GU's clinical partner, MedStar Health, Inc. In FY02, Lombardi clinical services served more than 22,000 outpatient cancer visits, and 603 patients were enrolled on Lombardi clinical trials. Outpatient cancer visits have increased to 39,000 in 2008, with 1,169 people placed on interventional trials.”
Lab suppliers marketing university lab equipment and life science products may be interested in getting to know the Georgetown University market better at Washington, D.C. life science marketing events. Biotechnology Calendar, Inc. invites all lab suppliers interested in selling university lab equipment and life science products to attend our annual Georgetown BioResearch Product Faire™ Event held on October 17, 2013. Last year, the Georgetown BioResearch Product Faire™ Event attracted 223 attendees. Of the attendees, 59 were purchasing agents, professors and post docs, and 24 were lab managers. The visitors came from 13 different research buildings and 21 departments around campus.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes life science marketing events at top research universities nationwide. If you’d like to market your university lab equipment and life science products at life science marketing events closer to home, we encourage you to view our 2013 calendar of events. For more funding statistics for Georgetown University, or to learn more about our Georgetown BioResearch Product Faire™ Event, click on the button below.
